List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 44 studies with search of: "Zalcitabine" [TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Completed A Study of Saquinavir and Zalcitabine, Used Alone and Together, in the Treatment of Advanced HIV Infection in Patients Who Stopped Taking or Who Cannot Take Zidovudine
Condition: HIV Infections
Interventions: Drug: Saquinavir;   Drug: Zalcitabine
2 Completed Comparison of Ro 31-8959 Plus Zidovudine (AZT) Versus AZT Plus Zalcitabine (ddC) Versus Ro 31-8959 Plus AZT Plus ddC
Condition: HIV Infections
Interventions: Drug: Saquinavir;   Drug: Zidovudine;   Drug: Zalcitabine
3 Completed An Open-Label Safety Program for the Use of Zalcitabine (Dideoxycytidine; ddC) in Pediatric Patients With Symptomatic HIV Infection Who Have Failed or Are Intolerant to AZT Monotherapy, or Who Have Completed Other ddC Protocols, or Are Ineligible for Other Ongoing Clinical Studies
Condition: HIV Infections
Intervention: Drug: Zalcitabine
4 Completed Dideoxycytidine ( Ro 24-2027 ). A Treatment Protocol for the Use of Dideoxycytidine ( ddC ) in Patients With AIDS or Advanced ARC Who Cannot Be Maintained on Zidovudine ( AZT ) Therapy.
Condition: HIV Infections
Intervention: Drug: Zalcitabine
5 Completed A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection
Condition: HIV Infections
Interventions: Drug: Zidovudine;   Drug: Zalcitabine
6 Completed Dideoxycytidine ( Ro 24-2027 ) A Randomized, Open-Label, Comparative Study of Dideoxycytidine ( ddC ) Versus Zidovudine ( AZT ) in Patients With AIDS or Advanced ARC Who Have Received Long-Term AZT Therapy.
Condition: HIV Infections
Interventions: Drug: Zidovudine;   Drug: Zalcitabine
7 Completed A Multicenter Dose Ranging Clinical Trial of 2',3'-Dideoxycytidine in the Treatment of Patients With AIDS and Advanced ARC.
Condition: HIV Infections
Intervention: Drug: Zalcitabine
8 Completed The Safety and Effectiveness of Retrovir Plus HIVID Combined With Either Nevirapine or Invirase in the Treatment of HIV Infection
Condition: HIV Infections
Interventions: Drug: Saquinavir;   Drug: Nevirapine;   Drug: Zidovudine;   Drug: Zalcitabine
9 Completed A Study of Dideoxycytidine in HIV-Infected Patients
Condition: HIV Infections
Intervention: Drug: Zalcitabine
10 Completed A Trial of Alternating 2',3'-Dideoxycytidine and Zidovudine in the Treatment of Patients With Advanced HIV Disease
Condition: HIV Infections
Interventions: Drug: Zidovudine;   Drug: Zalcitabine
11 Completed A Study of Dideoxycytidine Plus Zidovudine in the Treatment of AIDS or Advanced AIDS Related Complex (ARC)
Condition: HIV Infections
Interventions: Drug: Zidovudine;   Drug: Zalcitabine
12 Completed Open-Label Program of Dideoxycytidine ( ddC ) to Be Used in Combination With Zidovudine ( AZT ) for Treatment of Advanced HIV Disease
Condition: HIV Infections
Interventions: Drug: Zidovudine;   Drug: Zalcitabine
13 Completed A Study of Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken AZT
Condition: HIV Infections
Interventions: Drug: Zidovudine;   Drug: Zalcitabine
14 Completed A Comparison of Zidovudine (AZT) Used Alone or in Combination With Didanosine (ddI) or Dideoxycytidine (ddC) in HIV-Infected Patients
Condition: HIV Infections
Interventions: Drug: Zidovudine;   Drug: Zalcitabine;   Drug: Didanosine
15 Completed The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-Dideoxyinosine or 2',3'-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease
Condition: HIV Infections
Interventions: Drug: Zidovudine;   Drug: Zalcitabine;   Drug: Didanosine
16 Completed (Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) Versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC
Condition: HIV Infections
Interventions: Drug: Zidovudine;   Drug: Zalcitabine
17 Completed A Clinical Trial of Alternating and Intermittent Regimens of 2',3'-Dideoxycytidine and 3'-Azido-3'-Deoxythymidine in the Treatment of Patients With AIDS and Advanced ARC
Condition: HIV Infections
Interventions: Drug: Zidovudine;   Drug: Zalcitabine
18 Completed A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT
Condition: HIV Infections
Intervention: Drug: Zalcitabine
19 Completed An Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of Dideoxycytidine (ddC) in Patients With AIDS or Advanced ARC Who Previously Demonstrated Intolerance to Zidovudine (AZT) in Protocol N3300 or N3492
Condition: HIV Infections
Intervention: Drug: Zalcitabine
20 Completed A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3
Condition: HIV Infections
Interventions: Drug: Interferon alfa-2a;   Drug: Zidovudine;   Drug: Zalcitabine

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services